Search results
Results from the WOW.Com Content Network
M9876/3 Atypical chronic myelogenous leukemia BCR/ABL negative Atypical chronic myeloid leukemia (BCR/ABL negative)/(Ph1 negative) M9891/3 Acute monoblastic and monocytic leukemia. Monoblastic leukemia, NOS; FAB M5 (includes all variants) M9895/3 Acute myeloid leukemia multilineage dysplasia. AML with/without prior myelodysplastic syndrome
Lymphoid leukemias are a group of leukemias affecting circulating lymphocytes, a type of white blood cell.The lymphocytic leukemias are closely related to lymphomas of the lymphocytes, to the point that some of them are unitary disease entities that can be called by either name (for example, adult T-cell leukemia/lymphoma).
Types include (with ICD-O code): [citation needed] 9823/3 - B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma; 9826/3 - Acute lymphoblastic leukemia, mature B-cell type; 9833/3 - B-cell prolymphocytic leukemia; 9835/3-9836/3 - Precursor B lymphoblastic leukemia; 9940/3 - Hairy cell leukemia
Acute myeloid leukemia (AML) 8.7% Chronic lymphocytic leukemia (CLL) sorted under lymphomas according to current WHO classification; called small lymphocytic lymphoma (SLL) when leukemic cells are absent. 10.2% Chronic myelogenous leukemia (CML) 3.7% Acute monocytic leukemia (AMoL) 0.7% Other leukemias 3.1% Lymphomas — 55.6%
Blastic phase chronic myelogenous leukemia is a phase of chronic myelogenous leukemia in which more than 30% of the cells in the blood or bone marrow are blast cells. Stem cell leukemia: Chronic leukaemia of unspecified cell type: Subacute leukaemia of unspecified cell type: Accelerated phase chronic myelogenous leukemia: Acute myeloid leukemia ...
The ICD-10 Clinical Modification (ICD-10-CM) is a set of diagnosis codes used in the United States of America. [1] It was developed by a component of the U.S. Department of Health and Human services, [ 2 ] as an adaption of the ICD-10 with authorization from the World Health Organization .
In aCML many clinical features (splenomegaly, myeloid predominance in the bone marrow with some dysplastic features but without a differentiation block) and laboratory abnormalities (myeloid proliferation, low leukocyte alkaline phosphatase values) suggest the diagnosis of chronic myelogenous leukemia (CML).
CLL has also been reported to convert into other more aggressive diseases such as lymphoblastic lymphoma, hairy cell leukemia, high grade T cell lymphomas, [25] acute myeloid leukemia, [26] lung cancer, brain cancer, melanoma of the eye or skin, [27] [28] salivary gland tumors, and Kaposi's sarcomas. [29]